The EpiMark® suite, and our complementary groups of separately applicable methylation-dependent or sensitive restriction endonucleases, recombinant histones, DNA methyltransferases, protein methyltransferases, antibodies and DNA controls, are expertly designed for reliable and simplified analysis of DNA modifications and associated protein epigenetic regulators.

EpiMark® is a registered trademark of New England Biolabs, Inc.